Search Results - "Mizuki, Masao"

Refine Results
  1. 1
  2. 2

    Clinicopathologic characteristics of 342 patients with multicentric Castleman disease in Japan by Murakami, Miho, Johkoh, Takeshi, Hayashi, Seiji, Ohshima, Shiro, Mizuki, Masao, Nakatsuka, Shin-ichi, Tomobe, Minako, Kuroyanagi, Kazuyuki, Nakasone, Ayako, Nishimoto, Norihiro

    Published in Modern rheumatology (02-09-2020)
    “…Objectives: To assess the clinicopathologic features of Multicentric Castleman disease (MCD) patients in Japan. Methods: We assessed baseline data for 342…”
    Get full text
    Journal Article
  3. 3

    Roles for deregulated receptor tyrosine kinases and their downstream signaling molecules in hematologic malignancies by Matsumura, Itaru, Mizuki, Masao, Kanakura, Yuzuru

    Published in Cancer science (01-03-2008)
    “…Growth, survival and differentiation of hematopoietic cells are regulated by the interactions between hematopoietic growth factors and their receptors. The…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Suppression of myeloid transcription factors and induction of STAT response genes by AML-specific Flt3 mutations by Mizuki, Masao, Schwäble, Joachim, Steur, Claudia, Choudhary, Chunaram, Agrawal, Shuchi, Sargin, Bülent, Steffen, Björn, Matsumura, Itaru, Kanakura, Yuzuru, Böhmer, Frank D., Müller-Tidow, Carsten, Berdel, Wolfgang E., Serve, Hubert

    Published in Blood (15-04-2003)
    “…The receptor tyrosine kinase Flt3 is expressed and functionally important in early myeloid progenitor cells and in the majority of acute myeloid leukemia (AML)…”
    Get full text
    Journal Article
  6. 6

    The Scaffolding Adapter Gab2, via Shp-2, Regulates Kit-evoked Mast Cell Proliferation by Activating the Rac/JNK Pathway by Yu, Min, Luo, Jincai, Yang, Wentian, Wang, Yongping, Mizuki, Masao, Kanakura, Yuzuru, Besmer, Peter, Neel, Benjamin G., Gu, Haihua

    Published in The Journal of biological chemistry (29-09-2006)
    “…The scaffolding adapter Gab2 mediates cell signaling and responses evoked by various extracellular stimuli including several growth factors. Kit, the receptor…”
    Get full text
    Journal Article
  7. 7

    Roles for c-Myc in Self-renewal of Hematopoietic Stem Cells by Satoh, Yusuke, Matsumura, Itaru, Tanaka, Hirokazu, Ezoe, Sachiko, Sugahara, Hiroyuki, Mizuki, Masao, Shibayama, Hirohiko, Ishiko, Eri, Ishiko, Jun, Nakajima, Koichi, Kanakura, Yuzuru

    Published in The Journal of biological chemistry (11-06-2004)
    “…Notch and HOXB4 have been reported to expand hematopoietic stem cells (HSCs) in vitro. However, their critical effector molecules remain undetermined. We found…”
    Get full text
    Journal Article
  8. 8

    The development history and future perspective of molecularly targeted therapy by Mizuki, Masao, Kanakura, Yuzuru

    Published in Nihon rinshō (01-06-2014)
    “…The origin of molecularly targeted drugs dates back to 'magic bullet' theory proposed by Paul Ehrlich. The success of Abl tyrosine kinase inhibitor, imatinib…”
    Get more information
    Journal Article
  9. 9

    AML1/RUNX1 Works as a Negative Regulator of c-Mpl in Hematopoietic Stem Cells by Satoh, Yusuke, Matsumura, Itaru, Tanaka, Hirokazu, Ezoe, Sachiko, Fukushima, Kentaro, Tokunaga, Masahiro, Yasumi, Masato, Shibayama, Hirohiko, Mizuki, Masao, Era, Takumi, Okuda, Tsukasa, Kanakura, Yuzuru

    Published in The Journal of biological chemistry (31-10-2008)
    “…In this study, we analyzed the roles for AML1/RUNX1 in the regulation of the c-mpl promoter. Wild-type AML1 activated the c-mpl promoter through the proximal…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12
  13. 13

    Functional Cooperation among Ras, STAT5, and Phosphatidylinositol 3-Kinase Is Required for Full Oncogenic Activities of BCR/ABL in K562 Cells by Sonoyama, Junko, Matsumura, Itaru, Ezoe, Sachiko, Satoh, Yusuke, Zhang, Xian, Kataoka, Yoshihisa, Takai, Emi, Mizuki, Masao, Machii, Takashi, Wakao, Hiroshi, Kanakura, Yuzuru

    Published in The Journal of biological chemistry (08-03-2002)
    “…BCR/ABL tyrosine kinase generated from the chromosomal translocation t(9;22) causes chronic myelogenous leukemia and acute lymphoblastic leukemia. To examine…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Effect of the administration of zoledronic acid on life expectancy in patients with multiple myeloma with or without renal impairment by Morio, Kayoko, Tsugane, Mamiko, Mizuki, Masao, Uejima, Etsuko

    Published in Gan to kagaku ryoho (01-04-2014)
    “…Zoledronic acid(ZA)is believed to exert anticancer effects in patients with multiple myeloma(MM). For patients with impaired renal function, its dosage should…”
    Get more information
    Journal Article
  16. 16
  17. 17

    Distinct role for c-kit receptor tyrosine kinase and SgIGSF adhesion molecule in attachment of mast cells to fibroblasts by KOMA, Yu-Ichiro, ITO, Akihiko, WATABE, Kenji, HIRATA, Tatsumi, MIZUKI, Masao, YOKOZAKI, Hiroshi, KITAMURA, Toshio, KANAKURA, Yuzuru, KITAMURA, Yukihiko

    Published in Laboratory investigation (01-03-2005)
    “…Binding of stem cell factor (SCF) to c-kit receptor tyrosine kinase (KIT) transduces signals essential for mast cell development via several pathways including…”
    Get full text
    Journal Article
  18. 18
  19. 19

    Establishment and characterization of unique cell lines derived from pyothorax‐associated lymphoma which develops in long‐standing pyothorax and is strongly associated with Epstein‐Barr virus infection by Takakuwa, Tetsuya, Luo, Wen‐Juan, Ham, Maria Francisca, Mizuki, Masao, Iuchi, Keiji, Aozasa, Katsuyuki

    Published in Cancer science (01-10-2003)
    “…Malignant lymphoma frequently develops in the pleural cavity of patients with over 20 years' history of pyothorax. The term pyothorax‐associated lymphoma (PAL)…”
    Get full text
    Journal Article
  20. 20

    Roles of tyrosine residues 845, 892 and 922 in constitutive activation of murine FLT3 kinase domain mutant by ISHIKO, Jun, MIZUKI, Masao, MATSUMURA, Itaru, SHIBAYAMA, Hirohiko, SUGAHARA, Hiroyuki, SCHOLZ, Glen, SERVE, Hubert, KANAKURA, Yuzuru

    Published in Oncogene (08-12-2005)
    “…FLT3 tyrosine kinase domain (TKD) mutations are detected in approximately 7% of acute myeloid leukemia patients, and suggested to correlate with poor prognosis…”
    Get full text
    Journal Article